Categories: Entertainment

Xinhua Silk Road: Chinese tin industry giant to expand global presence with innovative endeavors

BEIJING, Nov. 28, 2025 /PRNewswire/ — Southwest China-situated refined tin producer Yunnan Tin Group (Holding) Co., Ltd. is revving up its paces to delve deeper into global tin market with innovation-led growth now.

- Advertisement -

After the century-old efforts, the Chinese tin industry giant has built up a complete industrial chain that covers mining, processing, smelting, tin materials, tin chemicals and related recycling, making it the world’s largest refined tin producer in past two decades.

- Advertisement -

Nowadays, the company’s products and materials are widely used in aviation, 5G communication, PV batteries, and semiconductor chips, enabling it to seize a solid foothold in global tin industry.

- Advertisement -

During 2021-2025, the company established the “4+2” industrial pattern where non-ferrous metal raw materials, supply chain and logistics, new materials and deep processing, and asset management and supporting industries co-pillared its core business together with sci-tech innovation and talent cultivation platforms.

- Advertisement -

Sun Yong, chairman of Yunnan Tin Group said that such an industrial pattern not only fortified the company’s existing advantages, but also laid a solid foundation for future-oriented fields. Since 2021, the company has incubated 17 more state- and provincial-level innovation platforms and entities.

- Advertisement -

A wide array of innovative technologies were thus born, including those breaking bottlenecks in high-end solder, soldering flux, ITO target materials, and high-purity materials for semiconductors.

- Advertisement -

For the next five years, Yunnan Tin Group has pinned down a development blueprint under which a special campaign to sharpen its competitiveness in mid- and high-end materials sector will be carried out, noted Sun.

- Advertisement -

Instead of separated breakthroughs, the company is aiming for systematic advantages and currently is shifting towards innovation-led value creation, according to Sun.

- Advertisement -

In the new era, leveraging a global prospective to win the future, participating in the Belt and Road cooperation and expediting the international drive are all efforts made by Yunnan Tin Group to expand global presence.

- Advertisement -

Sun outlined priorities of three aspects in this regard, namely opening-featuring cooperation to establish a globalized industrial layout, adherence to green development including developing green mines, clean production and circular economy, and quality-prioritized brand image.

- Advertisement -

With clear objectives and products of premium quality, Yunnan Tin Group is determined to be a leading comprehensive solutions provider for global tin and indium industries, Sun added.

- Advertisement -

Original link: https://en.imsilkroad.com/p/348509.html

- Advertisement -

Photo – https://mma.prnewswire.com/media/2833987/19380375e154471ca1085b40d4308434.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/xinhua-silk-road-chinese-tin-industry-giant-to-expand-global-presence-with-innovative-endeavors-302627879.html

- Advertisement -
PRNW Agency

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

3 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

7 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

7 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

7 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

7 hours ago